Skip to main content

Security report for axapharm.ch

axapharm ag · Healthcare · Switzerland

High risk. 7 critical or high findings in Network security, Security headers and 2 other checks.

Security score

49/100

Risk levelHigh

0–100, higher is better. How it is calculated

axapharm ag is a Swiss pharmaceutical company specializing in the distribution and manufacturing of generics, prescription, and over-the-counter medicines. With a unique shareholder structure involving over 700 Swiss pharmacists and druggists, the company positions itself as a reliable partner in the Swiss pharmaceutical market, emphasizing Swiss quality and affordable healthcare products. The website targets healthcare professionals and consumers within Switzerland, offering product information, services, and educational resources. Technically, the website is built on WordPress with modern plugins such as Elementor and LayerSlider, integrating Google Analytics and Maps for enhanced user experience. Security measures include HTTPS enforcement and standard security headers, though there is room for improvement in privacy compliance, particularly regarding cookie consent mechanisms. Overall, the website reflects a professional and trustworthy digital presence aligned with the company's business model and market position.

Scanned

NIS2 and GDPR posture

GDPR outside view
58/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

  2. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  3. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching axapharm.ch

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
72
Security headers
40
Email security
85
DNS health
75
Network security
0
GDPR outside view
58
Average
55
After the cap
49

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

axapharm ag holds a strong position in the Swiss pharmaceutical sector, leveraging its local shareholder base to build trust and market presence. Its business model focuses on supplying affordable generics and health products to pharmacies and consumers, supported by digital services like the axapharm Academy and extranet portals. The company maintains partnerships with specialized service providers and promotes Swiss-made quality. Growth indicators include active engagement with healthcare professionals and a diversified product portfolio. The website's multilingual support (German, French, Italian) aligns with Switzerland's linguistic regions, enhancing market reach. Strategic observations suggest a focus on maintaining strong local ties and expanding digital service offerings to reinforce competitive advantage.

Security posture

The website demonstrates a mature security posture with HTTPS enabled and multiple security headers implemented, reducing common web vulnerabilities. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, the absence of a dedicated security policy and vulnerability disclosure mechanism limits transparency. Privacy compliance is partial, with a privacy policy present but lacking an explicit cookie consent mechanism. Incident response contact is provided via a quality assurance email, indicating some readiness for handling security or quality issues. Recommendations include implementing a cookie consent banner, publishing a security policy, and adding a vulnerability disclosure page to enhance security culture and compliance.

Recommendations

  1. Implement an explicit cookie consent mechanism to ensure full GDPR compliance.
  2. Publish a dedicated security policy page outlining security practices and commitments.
  3. Add a vulnerability disclosure or security.txt file to facilitate responsible reporting.
  4. Enhance accessibility features to improve compliance and user experience for all users.
  5. Conduct regular security audits of third-party plugins and update them promptly.

Contact details published on the site

Addresses
Legal name
axapharm ag
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
axapharm ag
Description
axapharm ag is a Swiss pharmaceutical company with over 700 Swiss pharmacists and druggists as shareholders and medication specialists. The company focuses on providing affordable health products from Swiss origin to the professional trade and consumers.
Key services
Distribution of prescription medicines, Distribution of non-prescription medicines, Freiverkäufliche (over-the-counter) products, Pharmaceutical services, Educational academy (axapharm Academy), Extranet and Fachbereich portals
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Elementor, LayerSlider, Yoast SEO, Google Analytics, Google Maps API, jQuery, Bootstrap, Font Awesome
Frameworks
WordPress, Elementor
Platforms
WordPress CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Security headers present
  • No exposed sensitive data in HTML
  • Use of reputable third-party libraries

Analytics and tracking

Services
Google Analytics, Google Tag Manager
Tracking level
moderate
Privacy practices
basic

Advertising

Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Content is focused on pharmaceutical products and services in Switzerland.
  3. Multiple language options available (de, fr, it).
  4. Clear contact information and corporate details provided.
  5. Use of modern web technologies and SEO best practices.
  6. No signs of malicious or suspicious activity.
  7. No explicit cookie consent mechanism detected despite cookie policy presence.
  8. Security headers and HTTPS are properly implemented.
Technical notes

Notes

The website is built on a robust WordPress CMS platform using Elementor for page building and LayerSlider for rich media content. It integrates modern libraries such as jQuery, Bootstrap, and Font Awesome, ensuring responsive and visually appealing design. SEO is enhanced via Yoast SEO plugin with proper meta tags and structured data (JSON-LD). Performance is moderate, with some large images and layered sliders that may impact load times. Mobile optimization is good, with responsive design elements and language switching capabilities. Accessibility is basic, with potential for improvement in ARIA roles and keyboard navigation. Hosting provider details are not explicitly identified. Overall, the technical infrastructure supports the business needs effectively but could benefit from performance tuning and enhanced accessibility.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with axapharm.ch. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review axapharm.ch.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.